Skip to content
Late-StageResearch compound

Clascoterone

Prescription skin treatment for acne that blocks the action of male hormones locally; against hair loss it is still being tested.

Available at
MINOXIDILMAX logo
MINOXIDILMAXProduct page

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Clascoterone vial

DETAILED OVERVIEW

What is Clascoterone?

Clascoterone is a prescription medicine applied to the skin, the first and so far only one approved in the United States to block the action of male hormones locally. In 2020 it was approved as a cream for acne (Winlevi). For male pattern hair loss (Breezula solution) it is still only being tested: a large, final-phase trial is under way, and it has no approval.

In sebaceous gland and hair follicle cells it occupies the binding site that DHT (dihydrotestosterone, a strong male hormone) would attach to. This reduces oil production and inflammation, and probably also the thinning of hairs in hair loss. After absorption it is quickly turned into an inactive substance, so it has little hormonal effect in the body. Two large studies confirmed its effect in acne; for hair loss the data are still being collected. The most common effects are mild redness, peeling or itching. Over a large area of skin it temporarily suppressed adrenal gland function in some patients, which returned to normal after treatment.

Development code / name

CB-03-01 · cortexolone 17α-propionate

Status

Acne: FDA-approved (Winlevi) · Hair (AGA): phase 3 investigational

Mechanism of action

Topical androgen-receptor antagonist (local anti-DHT)

Strengths

1% cream (acne) · 5-7.5% solution (investigational AGA)

Onset

4-12 weeks (acne); hair: months, during phase 3

Data console

Lab data

Classification-
StructureN/A
Molecular weightN/A
Target area-
Storage2–8°C
Stability~30 days reconstituted

Safety

Side effects, stop signs, contraindications

Side effects · 4

  • Local skin reactions: mild erythema, scaling, dryness, itching at the application site; in the phase 3 acne trials local reaction rates were similar to vehicle (well tolerated).
  • Signal of transient HPA-axis suppression: in a dedicated PK/safety study with large-area use a few patients showed transient, reversible adrenal-axis suppression; clinically minor but noted on the label.
  • With scalp application (investigational AGA solution): local irritation, itching, flaking; long-term data are still accruing as the AGA indication is in phase 3.
  • Hypersensitivity reaction (rare): contact dermatitis or more pronounced irritation; discontinue if an allergic reaction occurs.

Contraindications · 4

  • Known hypersensitivity to clascoterone or any excipient.
  • Broken, inflamed or infected skin: absorption and irritation may increase; withhold until it heals.
  • Large body-surface, prolonged use without HPA-axis monitoring: avoid due to the (rare, transient) adrenal-suppression risk, especially in children.
  • Pregnancy/breastfeeding: although systemic exposure is minimal (rapid inactivation to cortexolone), use only after benefit/risk assessment and under medical supervision due to limited data.

Related Hair & Skin

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about Clascoterone?

Educational hair and skin info from official sources (PubMed, FDA, EMA). Does NOT replace medical consultation. Talk to a dermatologist!

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 12, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.